Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 3514914, 9 pages
https://doi.org/10.1155/2017/3514914
Research Article

Tetramethylpyrazine Protects against Early Brain Injury after Experimental Subarachnoid Hemorrhage by Affecting Mitochondrial-Dependent Caspase-3 Apoptotic Pathway

1Department of Neurosurgery, School of Medicine, Southern Medical University, Jinling Hospital, 305 East Zhongshan Road, Nanjing, Jiangsu Province 210002, China
2Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, The Second Clinical School, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province 510120, China
3Surgery & Interventional Science, Royal Free Hospital, University College London Medical School, Pond Street, London, UK

Correspondence should be addressed to Chunhua Hang; moc.361@yregrusoruen_gnah

Received 10 October 2016; Revised 27 December 2016; Accepted 23 January 2017; Published 27 February 2017

Academic Editor: Shan-Yu Su

Copyright © 2017 Shaoxue Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. van Gijn, R. S. Kerr, and G. J. Rinkel, “Subarachnoid haemorrhage,” The Lancet, vol. 369, no. 9558, pp. 306–318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Vernal, E. Velásquez, J. Gamonal, J. A. Garcia-Sanz, A. Silva, and M. Sanz, “Expression of proinflammatory cytokines in osteoarthritis of the temporomandibular joint,” Archives of Oral Biology, vol. 53, no. 10, pp. 910–915, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. F. A. Sehba, J. Hou, R. M. Pluta, and J. H. Zhang, “The importance of early brain injury after subarachnoid hemorrhage,” Progress in Neurobiology, vol. 97, no. 1, pp. 14–37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Fujii, J. Yan, W. B. Rolland, Y. Soejima, B. Caner, and J. H. Zhang, “Early brain injury, an evolving frontier in subarachnoid hemorrhage research,” Translational Stroke Research, vol. 4, no. 4, pp. 432–446, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. C.-H. Jing, L. Wang, P.-P. Liu, C. Wu, D. Ruan, and G. Chen, “Autophagy activation is associated with neuroprotection against apoptosis via a mitochondrial pathway in a rat model of subarachnoid hemorrhage,” Neuroscience, vol. 213, pp. 144–153, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. P. Ostrowski, A. R. Colohan, and J. H. Zhang, “Molecular mechanisms of early brain injury after subarachnoid hemorrhage,” Neurological Research, vol. 28, no. 4, pp. 399–414, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Krieger and M. R. Duchen, “Mitochondria, Ca2+ and neurodegenerative disease,” European Journal of Pharmacology, vol. 447, no. 2-3, pp. 177–188, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Yan, D. Zhang, S. Hao, K. Li, and C.-H. Hang, “Role of mitochondrial calcium uniporter in early brain injury after experimental subarachnoid hemorrhage,” Molecular Neurobiology, vol. 52, no. 3, pp. 1637–1647, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. T. H. Sanderson, C. A. Reynolds, R. Kumar, K. Przyklenk, and M. Hüttemann, “Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation,” Molecular Neurobiology, vol. 47, no. 1, pp. 9–23, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Hu, F. Wang, J. Tang et al., “Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101,” Journal of Biological Chemistry, vol. 287, no. 1, pp. 68–80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Ni, S. Liu, and X. Guo, “Medium- and long-term efficacy of ligustrazine plus conventional medication on ischemic stroke: a systematic review and meta-analysis,” Journal of Traditional Chinese Medicine, vol. 33, no. 6, pp. 715–720, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Chang, G. Hsiao, S.-H. Chen et al., “Tetramethylpyrazine suppresses HIF-1α, TNF-α, and activated caspase-3 expression in middle cerebral artery occlusion-induced brain ischemia in rats,” Acta Pharmacologica Sinica, vol. 28, no. 3, pp. 327–333, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Fan, K. Wang, Z. Shi, J. Die, C. Wang, and X. Dang, “Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury,” Journal of Vascular Surgery, vol. 54, no. 1, pp. 192–200, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. X.-Y. Li, J.-L. He, H.-T. Liu, W.-M. Li, and C. Yu, “Tetramethylpyrazine suppresses interleukin-8 expression in LPS-stimulated human umbilical vein endothelial cell by blocking ERK, p38 and nulear factor-κB signaling pathways,” Journal of Ethnopharmacology, vol. 125, no. 1, pp. 83–89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C.-C. Wu, M.-H. Liao, S.-J. Chen, and M.-H. Yen, “Tetramethylpyrazine prevents inducible NO synthase expression and improves survival in rodent models of endotoxic shock,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 360, no. 4, pp. 435–444, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Zhang, T. Wei, J. Hou, G. Li, S. Yu, and W. Xin, “Tetramethylpyrazine scavenges superoxide anion and decreases nitric oxide production in human polymorphonuclear leukocytes,” Life Sciences, vol. 72, no. 22, pp. 2465–2472, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Jia, X. Zhang, Y.-S. Hu et al., “Protective effect of tetraethyl pyrazine against focal cerebral ischemia/reperfusion injury in rats: therapeutic time window and its mechanism,” Thrombosis Research, vol. 123, no. 5, pp. 727–730, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Xiao, Y. Liu, C. Qi et al., “Neuroprotection and enhanced neurogenesis by tetramethylpyrazine in adult rat brain after focal ischemia,” Neurological Research, vol. 32, no. 5, pp. 547–555, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. T.-K. Kao, C.-Y. Chang, Y.-C. Ou et al., “Tetramethylpyrazine reduces cellular inflammatory response following permanent focal cerebral ischemia in rats,” Experimental Neurology, vol. 247, pp. 188–201, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Gao, X. Liu, W. Liu et al., “Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following subarachnoid hemorrhage in rats,” Autonomic Neuroscience: Basic and Clinical, vol. 141, no. 1-2, pp. 22–30, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S.-Y. Li, Y.-H. Jia, W.-G. Sun et al., “Stabilization of mitochondrial function by tetramethylpyrazine protects against kainate-induced oxidative lesions in the rat hippocampus,” Free Radical Biology and Medicine, vol. 48, no. 4, pp. 597–608, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Sun, Y. Dai, X. Zhang et al., “Expression and cell distribution of myeloid differentiation primary response protein 88 in the cerebral cortex following experimental subarachnoid hemorrhage in rats: a pilot study,” Brain Research, vol. 1520, pp. 134–144, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Hsiao, Y.-C. Chen, J.-H. Lin et al., “Inhibitory mechanisms of tetramethylpyrazine in middle cerebral artery occlusion (MCAO)-induced focal cerebral ischemia in rats,” Planta Medica, vol. 72, no. 5, pp. 411–417, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Zhuang, M.-L. Zhou, W.-C. You et al., “Hydrogen-rich saline alleviates early brain injury via reducing oxidative stress and brain edema following experimental subarachnoid hemorrhage in rabbits,” BMC Neuroscience, vol. 13, no. 1, article 47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Zhou, M. Yamaguchi, G. Kusaka, C. Schonholz, A. Nanda, and J. H. Zhang, “Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 24, no. 4, pp. 419–431, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Hasenjäger, B. Gillissen, A. Müller et al., “Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-xL in a strictly caspase-3-dependent manner in human carcinoma cells,” Oncogene, vol. 23, no. 26, pp. 4523–4535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Kroemer, “Mitochondrial implication in apoptosis. Towards an endosymbiont hypothesis of apoptosis evolution,” Cell Death and Differentiation, vol. 4, no. 6, pp. 443–456, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. C. R. Arnt and S. H. Kaufmann, “The saintly side of Smac/DIABLO: giving anticancer drug-induced apoptosis a boost,” Cell Death and Differentiation, vol. 10, no. 10, pp. 1118–1120, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Oxenoid, Y. Dong, C. Cao et al., “Architecture of the mitochondrial calcium uniporter,” Nature, vol. 533, no. 7602, pp. 269–273, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Yan, S. Hao, X. Sun et al., “Blockage of mitochondrial calcium uniporter prevents iron accumulation in a model of experimental subarachnoid hemorrhage,” Biochemical and Biophysical Research Communications, vol. 456, no. 4, pp. 835–840, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. P. K. T. Pang, J. J. Shan, and K. W. Chiu, “Tetramethylpyrazine, a calcium antagonist,” Planta Medica, vol. 62, no. 5, pp. 431–435, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. W. J. Cahill, J. H. Calvert, and J. H. Zhang, “Mechanisms of early brain injury after subarachnoid hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 26, no. 11, pp. 1341–1353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. L.-H. Fan, K.-Z. Wang, B. Cheng, C.-S. Wang, and X.-Q. Dang, “Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following spinal cord ischemia in rabbits,” BMC Neuroscience, vol. 7, article no. 48, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Aoki, A. Y. Zubkov, I. B. Ross, and J. H. Zhang, “Therapeutic effect of caspase inhibitors in the prevention of apoptosis and reversal of chronic cerebral vasospasm,” Journal of Clinical Neuroscience, vol. 9, no. 6, pp. 672–677, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Boitier, R. Rea, and M. R. Duchen, “Mitochondria exert a negative feedback on the propagation of intracellular Ca2+ waves in rat cortical astrocytes,” The Journal of Cell Biology, vol. 145, no. 4, pp. 795–808, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. L. S. Jouaville, P. Pinton, C. Bastianutto, G. A. Rutter, and R. Rizzuto, “Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 24, pp. 13807–13812, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Gong, V. N. Ivanov, M. M. Davidson, and T. K. Hei, “Tetramethylpyrazine (TMP) protects against sodium arsenite-induced nephrotoxicity by suppressing ROS production, mitochondrial dysfunction, pro-inflammatory signaling pathways and programed cell death,” Archives of Toxicology, vol. 89, no. 7, pp. 1057–1070, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. Shao, J. Li, Z. Zhao, C. Gao, Z. Sun, and X. Liu, “Effects of tetramethylpyrazine on nitric oxide/cGMP signaling after cerebral vasospasm in rabbits,” Brain Research, vol. 1361, pp. 67–75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Philippon, R. Grob, F. Dagreou, M. Guggiari, M. Rivierez, and P. Viars, “Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine,” Acta Neurochirurgica, vol. 82, no. 3-4, pp. 110–114, 1986. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Biondi, G. K. Ricciardi, L. Puybasset et al., “Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results,” American Journal of Neuroradiology, vol. 25, no. 6, pp. 1067–1076, 2004. View at Google Scholar · View at Scopus
  41. D. T. Laskowitz and B. J. Kolls, “Neuroprotection in subarachnoid hemorrhage,” Stroke, vol. 41, no. 10, pp. S79–S84, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Steiner, S. Juvela, A. Unterberg, C. Jung, M. Forsting, and G. Rinkel, “European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage,” Cerebrovascular Diseases, vol. 35, no. 2, pp. 93–112, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Sabri, A. Kawashima, J. Ai, and R. L. Macdonald, “Neuronal and astrocytic apoptosis after subarachnoid hemorrhage: a possible cause for poor prognosis,” Brain Research, vol. 1238, pp. 163–171, 2008. View at Publisher · View at Google Scholar · View at Scopus